Drug Discovery World

JUNE 12, 2023

Those are the beginning of additional manufacturing, scale of chemistry pharmacokinetics, pharmacology assays, development bioanalytical assays, and then moving forward toxicology work to start the initial clinical trials. This time, we had two posters on expanded access.

Research 130

Research Clinical Trials Doctors Assay Development 130

Drug Target Review

OCTOBER 3, 2024

Overcoming traditional antibody generation limitations with recombinant technologies Antibodies remain essential tools in this ever-changing field for preclinical bioanalysis and drug monitoring through ligand-binding assays (LBAs). FDA no longer needs to require animal tests before human drug trials [Internet]. 2024 Jan 5;16(1).

Molecular Biology 52

Molecular Biology Pharmacokinetics Laboratories Animal Testing 52

Agency IQ

FEBRUARY 2, 2024

EMA finalizes clinical anticancer therapeutic guidance update In a newly finalized revision, the EMA’s guideline covering all aspects of clinical development of anticancer therapeutics has expanded its already broad scope. This enables patient selection, stratification and other adjustment in clinical trial design planning.

Clinical Trials 40

Clinical Trials Trials Treatment Production 40

Drug Discovery World

FEBRUARY 15, 2023

Rising demand The global immuno-oncology assay market is expected to grow at a compound annual growth rate (CAGR) of 11.87% from 2021 to 2030 to reach 11.74bn USD by 2030 7. Over 250 clinical trials are currently in progress, and novel immuno-oncological treatments are already proving to be successful. Cancer Statistics for the UK.

Research 130

Research Therapies Immune Response Clinical Trials 130